Few peptides in the research literature can claim a pedigree as long or as varied as GHK-Cu. First identified in 1973, this small copper-binding tripeptide has since become one of the most extensively studied signalling molecules in cell biology, wound repair science, and gene expression research. For laboratories investigating tissue remodelling, antioxidant defence, or regenerative biology, GHK-Cu remains a compound of genuine and growing interest.
In this overview, we walk through the science — from the peptide’s discovery through to the emerging research frontiers that continue to attract attention from investigators worldwide.
What Is GHK-Cu?
GHK-Cu is a naturally occurring tripeptide composed of three amino acids — glycine, L-histidine, and L-lysine — bound to a copper(II) ion. Its full chemical name is glycyl-L-histidyl-L-lysine:copper(II), and it carries a modest molecular weight of approximately 403.9 Da. The peptide has a strong, natural affinity for copper at physiological pH, and this copper-binding capacity is central to its biological activity.
GHK-Cu is not a synthetic invention. It has been isolated from human plasma, saliva, and urine, among other biological fluids. Plasma concentrations are estimated at roughly 200 ng/mL in young adults, a level that appears to decline with age — a detail that has not escaped the attention of researchers studying age-related changes in tissue repair and remodelling.
The peptide’s compact structure belies the breadth of its documented effects in laboratory models. Across hundreds of published studies, GHK-Cu has been associated with activity across wound repair, collagen synthesis, anti-inflammatory signalling, antioxidant regulation, and — more recently — large-scale gene expression modulation.
Discovery: Pickart and the Human Plasma Connection
The story of GHK-Cu begins with the work of Loren Pickart in 1973. Pickart, then working at the University of California, San Francisco, was investigating age-related differences in the bioactivity of human plasma. His experiments compared the effect of plasma from younger donors (aged 20–25) with that of older donors (aged 60–80) on hepatocyte (liver cell) function in vitro.
The finding was striking: a factor present in young plasma, but diminished in older plasma, appeared to promote a more youthful pattern of protein synthesis in cultured liver tissue. Pickart isolated the active component and identified it as the tripeptide GHK, which readily formed a complex with copper ions in solution.
This discovery opened a new avenue of inquiry. Over the following decades, Pickart and a growing community of researchers went on to document a remarkable range of biological effects attributable to this small peptide-copper complex in controlled laboratory environments.
Why Copper Matters: The Role of the Metal Ion
One of the most important aspects of GHK-Cu’s biology is the copper ion itself. GHK without copper is biologically far less active. The copper(II) ion is not merely a passenger — it is integral to the peptide’s mechanism of action.
Copper is a cofactor for a number of critical enzymes in mammalian biology, including superoxide dismutase (SOD), cytochrome c oxidase, and lysyl oxidase. GHK-Cu appears to function, at least in part, as a copper delivery vehicle, ferrying copper ions to cells and tissues where they are needed for enzymatic processes.
In cell culture studies, the presence of the copper ion has been shown to be essential for GHK-Cu’s effects on collagen synthesis, cell migration, and growth factor expression. Remove the copper, and many of these effects are substantially reduced or absent. This makes GHK-Cu a particularly interesting subject for researchers studying metal ion biology, metalloenzyme regulation, and the broader role of trace elements in cellular signalling.
Key Research Areas
Collagen Synthesis and Extracellular Matrix Remodelling
Among the earliest and most consistently documented effects of GHK-Cu in laboratory research is its influence on collagen production. In fibroblast culture models, GHK-Cu has been shown to stimulate the synthesis of collagen types I and III, the major structural proteins of the extracellular matrix (ECM).
Beyond simple collagen production, GHK-Cu also appears to influence ECM remodelling more broadly. Studies have reported effects on the expression of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs), suggesting that GHK-Cu does not merely promote matrix deposition but may help regulate the balance between matrix synthesis and degradation. This capacity for regulated remodelling — rather than unchecked accumulation — is one of the features that distinguishes GHK-Cu in the literature on tissue repair compounds.
Decorin and glycosaminoglycan synthesis have also been reported to increase in the presence of GHK-Cu in cell culture, pointing to effects on the non-collagenous components of the ECM as well.
Wound Healing Research
Wound healing has been a major focus of GHK-Cu research since the 1980s. In animal model studies, topical application of GHK-Cu has been associated with accelerated wound closure, increased angiogenesis (new blood vessel formation), and enhanced collagen deposition at wound sites.
Several in vivo studies using rodent wound models have reported that GHK-Cu treatment led to faster contraction of open wounds and increased tensile strength of healed tissue compared to controls. In vitro, GHK-Cu has been shown to promote the migration and proliferation of dermal fibroblasts and keratinocytes — two cell types central to wound repair.
Importantly, the wound healing effects observed in these models appear to extend beyond simple growth stimulation. GHK-Cu has been reported to promote a more organised pattern of tissue repair, with less disorganised scarring in some animal models. This has led researchers to describe GHK-Cu as a “remodelling” signal rather than simply a “growth” signal — a distinction with potentially significant implications for tissue engineering and regenerative biology research.
Anti-Inflammatory Effects
Chronic inflammation is increasingly recognised as a factor in impaired tissue repair and a range of degenerative processes. GHK-Cu has demonstrated anti-inflammatory properties in several in vitro and in vivo models.
In cell culture experiments, GHK-Cu has been shown to reduce the expression of pro-inflammatory cytokines, including interleukin-6 (IL-6) and tumour necrosis factor alpha (TNF-alpha), in activated immune cells. Some studies have also reported suppression of transforming growth factor beta (TGF-beta) signalling in contexts associated with fibrosis, suggesting a nuanced rather than blunt immunomodulatory profile.
These findings have attracted interest from researchers studying inflammatory skin conditions, fibrotic tissue responses, and the broader intersection of inflammation and tissue repair.
Antioxidant Enzyme Regulation
Oxidative stress — the accumulation of reactive oxygen species (ROS) — is a well-established contributor to cellular damage and is implicated in ageing, neurodegeneration, and tissue injury. GHK-Cu has been reported to influence antioxidant defence systems at the enzymatic level.
In particular, studies have shown that GHK-Cu can upregulate the expression of superoxide dismutase (SOD), one of the body’s primary enzymatic defences against superoxide radicals. Increases in glutathione peroxidase activity and glutathione levels have also been documented in cell culture models treated with GHK-Cu.
The copper ion’s role as a cofactor for Cu/Zn-SOD provides a plausible mechanistic link here: by delivering copper to cells, GHK-Cu may support the assembly and function of this critical antioxidant enzyme. This line of research has implications for any field in which oxidative damage is a factor, from neurobiology to cardiovascular science.
Gene Expression: A Broader Picture
Perhaps the most striking development in GHK-Cu research in recent years has been the work on gene expression profiling. In a landmark series of studies, Pickart and Campbell used connectivity mapping and gene expression databases to analyse the effects of GHK-Cu on the human genome at a systems level.
Their findings were remarkable. GHK-Cu was shown to significantly affect the expression of approximately 4,000 human genes — roughly 6% of the human genome. The affected genes were not randomly distributed; they clustered around functional pathways related to tissue remodelling, antioxidant defence, anti-inflammatory signalling, nerve growth, and stem cell biology.
Notably, GHK-Cu appeared to shift gene expression patterns in a direction associated with a “healthier” or more youthful baseline in the Connectivity Map database. Genes associated with tissue destruction and chronic inflammation tended to be downregulated, while genes associated with repair, antioxidant defence, and regeneration tended to be upregulated.
This gene expression work has repositioned GHK-Cu in the minds of many researchers — from a simple wound healing peptide to a potential broad-spectrum regulatory molecule with effects across multiple biological systems. It has also spurred new investigations into the mechanisms by which such a small molecule can exert such wide-ranging genomic effects.
Skin Biology and Fibroblast Research
Given its effects on collagen, ECM remodelling, and wound repair, it is no surprise that GHK-Cu has been studied extensively in the context of skin biology. Dermal fibroblast cultures treated with GHK-Cu consistently show increased proliferation, enhanced collagen production, and greater contractile activity in collagen gel assays.
Research has also examined GHK-Cu’s effects on skin thickness and elasticity in animal models. Studies in aged rodent skin have reported increased dermal thickness and improved structural organisation following topical GHK-Cu application, supporting the peptide’s reputation as a remodelling agent in skin tissue.
In vitro studies have additionally explored GHK-Cu’s interaction with growth factors involved in skin repair, including vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF). The peptide appears to promote angiogenic signalling, which is of particular interest in models of impaired healing where vascular insufficiency is a factor.
Hair Follicle Research
A more recent area of investigation involves GHK-Cu’s effects on hair follicle biology. Hair follicles are complex mini-organs that undergo cyclical phases of growth (anagen), regression (catagen), and rest (telogen). The transition between these phases is regulated by a network of signalling molecules, many of which overlap with pathways influenced by GHK-Cu.
In vitro studies have reported that GHK-Cu can stimulate the proliferation of dermal papilla cells — the specialised fibroblasts at the base of the hair follicle that are critical for hair growth signalling. Some researchers have also examined GHK-Cu’s potential to prolong the anagen phase or support follicular neogenesis in skin organ culture models, though this remains an early-stage area of research.
The overlap between GHK-Cu’s known effects (Wnt pathway modulation, growth factor expression, ECM remodelling) and the known regulatory pathways of the hair cycle makes this a logical area of inquiry, and one likely to see further attention in coming years.
Emerging Research Frontiers
Neuroprotection
Several studies have begun to explore GHK-Cu in neurobiological contexts. In cell culture models of neuronal injury, GHK-Cu has shown protective effects against oxidative damage and inflammatory cytotoxicity. The peptide’s ability to upregulate antioxidant enzymes and modulate inflammatory signalling is of particular interest in neurodegenerative disease models, where oxidative stress and chronic neuroinflammation are prominent features.
Gene expression data from Pickart and Campbell’s work also identified nerve growth-related genes among those upregulated by GHK-Cu, lending further support to the investigation of neuroprotective applications. While this research is still in its early stages, the mechanistic rationale for further study is well-supported.
Bone Regeneration
GHK-Cu has also attracted attention in orthopaedic and bone biology research. In vitro studies have demonstrated effects on osteoblast differentiation and activity, with GHK-Cu-treated cultures showing increased markers of bone formation. Some researchers have incorporated GHK-Cu into scaffold materials for bone tissue engineering, reporting improved cell attachment, proliferation, and mineralisation in these systems.
The copper ion’s known role in angiogenesis — new blood vessel formation is critical for bone healing — adds another layer of relevance. As scaffold-based and biomaterial approaches to bone repair continue to develop, GHK-Cu is likely to feature in ongoing material science and regenerative medicine research.
Current State of Research and Future Directions
After more than five decades of study, GHK-Cu occupies an unusual position in the research landscape. It is a naturally occurring, well-characterised molecule with a large and growing body of published literature, yet many of its mechanisms of action remain only partially understood. How does a tripeptide of just three amino acids and a metal ion influence the expression of thousands of genes? What are the receptor-level interactions that mediate its effects? These are open questions that continue to drive research.
The advent of high-throughput genomics, proteomics, and systems biology tools has given researchers new ways to interrogate GHK-Cu’s activity at a molecular level. We can expect to see more detailed pathway analyses, more sophisticated in vivo models, and greater integration of GHK-Cu research with broader trends in regenerative medicine, biomaterials science, and precision biology.
For researchers, GHK-Cu represents a compelling research tool: a small, stable, well-documented molecule with demonstrable effects across a wide range of biological systems, from fibroblast proliferation to genome-wide gene expression modulation.
Handling and Storage Notes for Researchers
GHK-Cu is typically supplied as a lyophilised (freeze-dried) powder with high purity (commonly 98%+). For optimal stability, the lyophilised peptide should be stored at -20 degrees Celsius in a dry environment, protected from light and moisture. Under these conditions, the peptide remains stable for extended periods.
Once reconstituted, GHK-Cu solutions should be aliquoted to avoid repeated freeze-thaw cycles, which can degrade peptide integrity. Reconstitution is commonly performed in sterile water or bacteriostatic water, depending on the application. Working solutions should be stored at 2-8 degrees Celsius and used within a reasonable timeframe, as peptides in solution are generally less stable than in lyophilised form.
As with all research peptides, GHK-Cu is intended for laboratory and research use only. Researchers should follow standard laboratory safety protocols and consult relevant material safety data sheets before handling.
This article is provided for educational and informational purposes only. GHK-Cu is sold as a research peptide for in vitro and in vivo laboratory research. It is not intended for human consumption, therapeutic use, or diagnostic purposes. All research should be conducted in accordance with applicable institutional, local, and national regulations.
Trusted Peptides supplies research-grade peptides to qualified researchers and institutions. For product specifications, certificates of analysis, and ordering information, visit our website.
GHK-Cu: The Copper Peptide with Over 50 Years of Research Behind It
Few peptides in the research literature can claim a pedigree as long or as varied as GHK-Cu. First identified in 1973, this small copper-binding tripeptide has since become one of the most extensively studied signalling molecules in cell biology, wound repair science, and gene expression research. For laboratories investigating tissue remodelling, antioxidant defence, or regenerative biology, GHK-Cu remains a compound of genuine and growing interest.
In this overview, we walk through the science — from the peptide’s discovery through to the emerging research frontiers that continue to attract attention from investigators worldwide.
What Is GHK-Cu?
GHK-Cu is a naturally occurring tripeptide composed of three amino acids — glycine, L-histidine, and L-lysine — bound to a copper(II) ion. Its full chemical name is glycyl-L-histidyl-L-lysine:copper(II), and it carries a modest molecular weight of approximately 403.9 Da. The peptide has a strong, natural affinity for copper at physiological pH, and this copper-binding capacity is central to its biological activity.
GHK-Cu is not a synthetic invention. It has been isolated from human plasma, saliva, and urine, among other biological fluids. Plasma concentrations are estimated at roughly 200 ng/mL in young adults, a level that appears to decline with age — a detail that has not escaped the attention of researchers studying age-related changes in tissue repair and remodelling.
The peptide’s compact structure belies the breadth of its documented effects in laboratory models. Across hundreds of published studies, GHK-Cu has been associated with activity across wound repair, collagen synthesis, anti-inflammatory signalling, antioxidant regulation, and — more recently — large-scale gene expression modulation.
Discovery: Pickart and the Human Plasma Connection
The story of GHK-Cu begins with the work of Loren Pickart in 1973. Pickart, then working at the University of California, San Francisco, was investigating age-related differences in the bioactivity of human plasma. His experiments compared the effect of plasma from younger donors (aged 20–25) with that of older donors (aged 60–80) on hepatocyte (liver cell) function in vitro.
The finding was striking: a factor present in young plasma, but diminished in older plasma, appeared to promote a more youthful pattern of protein synthesis in cultured liver tissue. Pickart isolated the active component and identified it as the tripeptide GHK, which readily formed a complex with copper ions in solution.
This discovery opened a new avenue of inquiry. Over the following decades, Pickart and a growing community of researchers went on to document a remarkable range of biological effects attributable to this small peptide-copper complex in controlled laboratory environments.
Why Copper Matters: The Role of the Metal Ion
One of the most important aspects of GHK-Cu’s biology is the copper ion itself. GHK without copper is biologically far less active. The copper(II) ion is not merely a passenger — it is integral to the peptide’s mechanism of action.
Copper is a cofactor for a number of critical enzymes in mammalian biology, including superoxide dismutase (SOD), cytochrome c oxidase, and lysyl oxidase. GHK-Cu appears to function, at least in part, as a copper delivery vehicle, ferrying copper ions to cells and tissues where they are needed for enzymatic processes.
In cell culture studies, the presence of the copper ion has been shown to be essential for GHK-Cu’s effects on collagen synthesis, cell migration, and growth factor expression. Remove the copper, and many of these effects are substantially reduced or absent. This makes GHK-Cu a particularly interesting subject for researchers studying metal ion biology, metalloenzyme regulation, and the broader role of trace elements in cellular signalling.
Key Research Areas
Collagen Synthesis and Extracellular Matrix Remodelling
Among the earliest and most consistently documented effects of GHK-Cu in laboratory research is its influence on collagen production. In fibroblast culture models, GHK-Cu has been shown to stimulate the synthesis of collagen types I and III, the major structural proteins of the extracellular matrix (ECM).
Beyond simple collagen production, GHK-Cu also appears to influence ECM remodelling more broadly. Studies have reported effects on the expression of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs), suggesting that GHK-Cu does not merely promote matrix deposition but may help regulate the balance between matrix synthesis and degradation. This capacity for regulated remodelling — rather than unchecked accumulation — is one of the features that distinguishes GHK-Cu in the literature on tissue repair compounds.
Decorin and glycosaminoglycan synthesis have also been reported to increase in the presence of GHK-Cu in cell culture, pointing to effects on the non-collagenous components of the ECM as well.
Wound Healing Research
Wound healing has been a major focus of GHK-Cu research since the 1980s. In animal model studies, topical application of GHK-Cu has been associated with accelerated wound closure, increased angiogenesis (new blood vessel formation), and enhanced collagen deposition at wound sites.
Several in vivo studies using rodent wound models have reported that GHK-Cu treatment led to faster contraction of open wounds and increased tensile strength of healed tissue compared to controls. In vitro, GHK-Cu has been shown to promote the migration and proliferation of dermal fibroblasts and keratinocytes — two cell types central to wound repair.
Importantly, the wound healing effects observed in these models appear to extend beyond simple growth stimulation. GHK-Cu has been reported to promote a more organised pattern of tissue repair, with less disorganised scarring in some animal models. This has led researchers to describe GHK-Cu as a “remodelling” signal rather than simply a “growth” signal — a distinction with potentially significant implications for tissue engineering and regenerative biology research.
Anti-Inflammatory Effects
Chronic inflammation is increasingly recognised as a factor in impaired tissue repair and a range of degenerative processes. GHK-Cu has demonstrated anti-inflammatory properties in several in vitro and in vivo models.
In cell culture experiments, GHK-Cu has been shown to reduce the expression of pro-inflammatory cytokines, including interleukin-6 (IL-6) and tumour necrosis factor alpha (TNF-alpha), in activated immune cells. Some studies have also reported suppression of transforming growth factor beta (TGF-beta) signalling in contexts associated with fibrosis, suggesting a nuanced rather than blunt immunomodulatory profile.
These findings have attracted interest from researchers studying inflammatory skin conditions, fibrotic tissue responses, and the broader intersection of inflammation and tissue repair.
Antioxidant Enzyme Regulation
Oxidative stress — the accumulation of reactive oxygen species (ROS) — is a well-established contributor to cellular damage and is implicated in ageing, neurodegeneration, and tissue injury. GHK-Cu has been reported to influence antioxidant defence systems at the enzymatic level.
In particular, studies have shown that GHK-Cu can upregulate the expression of superoxide dismutase (SOD), one of the body’s primary enzymatic defences against superoxide radicals. Increases in glutathione peroxidase activity and glutathione levels have also been documented in cell culture models treated with GHK-Cu.
The copper ion’s role as a cofactor for Cu/Zn-SOD provides a plausible mechanistic link here: by delivering copper to cells, GHK-Cu may support the assembly and function of this critical antioxidant enzyme. This line of research has implications for any field in which oxidative damage is a factor, from neurobiology to cardiovascular science.
Gene Expression: A Broader Picture
Perhaps the most striking development in GHK-Cu research in recent years has been the work on gene expression profiling. In a landmark series of studies, Pickart and Campbell used connectivity mapping and gene expression databases to analyse the effects of GHK-Cu on the human genome at a systems level.
Their findings were remarkable. GHK-Cu was shown to significantly affect the expression of approximately 4,000 human genes — roughly 6% of the human genome. The affected genes were not randomly distributed; they clustered around functional pathways related to tissue remodelling, antioxidant defence, anti-inflammatory signalling, nerve growth, and stem cell biology.
Notably, GHK-Cu appeared to shift gene expression patterns in a direction associated with a “healthier” or more youthful baseline in the Connectivity Map database. Genes associated with tissue destruction and chronic inflammation tended to be downregulated, while genes associated with repair, antioxidant defence, and regeneration tended to be upregulated.
This gene expression work has repositioned GHK-Cu in the minds of many researchers — from a simple wound healing peptide to a potential broad-spectrum regulatory molecule with effects across multiple biological systems. It has also spurred new investigations into the mechanisms by which such a small molecule can exert such wide-ranging genomic effects.
Skin Biology and Fibroblast Research
Given its effects on collagen, ECM remodelling, and wound repair, it is no surprise that GHK-Cu has been studied extensively in the context of skin biology. Dermal fibroblast cultures treated with GHK-Cu consistently show increased proliferation, enhanced collagen production, and greater contractile activity in collagen gel assays.
Research has also examined GHK-Cu’s effects on skin thickness and elasticity in animal models. Studies in aged rodent skin have reported increased dermal thickness and improved structural organisation following topical GHK-Cu application, supporting the peptide’s reputation as a remodelling agent in skin tissue.
In vitro studies have additionally explored GHK-Cu’s interaction with growth factors involved in skin repair, including vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF). The peptide appears to promote angiogenic signalling, which is of particular interest in models of impaired healing where vascular insufficiency is a factor.
Hair Follicle Research
A more recent area of investigation involves GHK-Cu’s effects on hair follicle biology. Hair follicles are complex mini-organs that undergo cyclical phases of growth (anagen), regression (catagen), and rest (telogen). The transition between these phases is regulated by a network of signalling molecules, many of which overlap with pathways influenced by GHK-Cu.
In vitro studies have reported that GHK-Cu can stimulate the proliferation of dermal papilla cells — the specialised fibroblasts at the base of the hair follicle that are critical for hair growth signalling. Some researchers have also examined GHK-Cu’s potential to prolong the anagen phase or support follicular neogenesis in skin organ culture models, though this remains an early-stage area of research.
The overlap between GHK-Cu’s known effects (Wnt pathway modulation, growth factor expression, ECM remodelling) and the known regulatory pathways of the hair cycle makes this a logical area of inquiry, and one likely to see further attention in coming years.
Emerging Research Frontiers
Neuroprotection
Several studies have begun to explore GHK-Cu in neurobiological contexts. In cell culture models of neuronal injury, GHK-Cu has shown protective effects against oxidative damage and inflammatory cytotoxicity. The peptide’s ability to upregulate antioxidant enzymes and modulate inflammatory signalling is of particular interest in neurodegenerative disease models, where oxidative stress and chronic neuroinflammation are prominent features.
Gene expression data from Pickart and Campbell’s work also identified nerve growth-related genes among those upregulated by GHK-Cu, lending further support to the investigation of neuroprotective applications. While this research is still in its early stages, the mechanistic rationale for further study is well-supported.
Bone Regeneration
GHK-Cu has also attracted attention in orthopaedic and bone biology research. In vitro studies have demonstrated effects on osteoblast differentiation and activity, with GHK-Cu-treated cultures showing increased markers of bone formation. Some researchers have incorporated GHK-Cu into scaffold materials for bone tissue engineering, reporting improved cell attachment, proliferation, and mineralisation in these systems.
The copper ion’s known role in angiogenesis — new blood vessel formation is critical for bone healing — adds another layer of relevance. As scaffold-based and biomaterial approaches to bone repair continue to develop, GHK-Cu is likely to feature in ongoing material science and regenerative medicine research.
Current State of Research and Future Directions
After more than five decades of study, GHK-Cu occupies an unusual position in the research landscape. It is a naturally occurring, well-characterised molecule with a large and growing body of published literature, yet many of its mechanisms of action remain only partially understood. How does a tripeptide of just three amino acids and a metal ion influence the expression of thousands of genes? What are the receptor-level interactions that mediate its effects? These are open questions that continue to drive research.
The advent of high-throughput genomics, proteomics, and systems biology tools has given researchers new ways to interrogate GHK-Cu’s activity at a molecular level. We can expect to see more detailed pathway analyses, more sophisticated in vivo models, and greater integration of GHK-Cu research with broader trends in regenerative medicine, biomaterials science, and precision biology.
For researchers, GHK-Cu represents a compelling research tool: a small, stable, well-documented molecule with demonstrable effects across a wide range of biological systems, from fibroblast proliferation to genome-wide gene expression modulation.
Handling and Storage Notes for Researchers
GHK-Cu is typically supplied as a lyophilised (freeze-dried) powder with high purity (commonly 98%+). For optimal stability, the lyophilised peptide should be stored at -20 degrees Celsius in a dry environment, protected from light and moisture. Under these conditions, the peptide remains stable for extended periods.
Once reconstituted, GHK-Cu solutions should be aliquoted to avoid repeated freeze-thaw cycles, which can degrade peptide integrity. Reconstitution is commonly performed in sterile water or bacteriostatic water, depending on the application. Working solutions should be stored at 2-8 degrees Celsius and used within a reasonable timeframe, as peptides in solution are generally less stable than in lyophilised form.
As with all research peptides, GHK-Cu is intended for laboratory and research use only. Researchers should follow standard laboratory safety protocols and consult relevant material safety data sheets before handling.
This article is provided for educational and informational purposes only. GHK-Cu is sold as a research peptide for in vitro and in vivo laboratory research. It is not intended for human consumption, therapeutic use, or diagnostic purposes. All research should be conducted in accordance with applicable institutional, local, and national regulations.
Trusted Peptides supplies research-grade peptides to qualified researchers and institutions. For product specifications, certificates of analysis, and ordering information, visit our website.